Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Stoke Therapeutics Inc buy Credit Suisse Group AG

Start price
€4.88
08.08.23 / 50%
Target price
€21.00
08.08.24
Performance (%)
51.64%
Price
€7.45
28.02.24
Summary
This prediction is currently active. With a performance of 51.64% the BUY prediction by Credit_Suisse_Group_ is a big success. This prediction currently runs until 08.08.24. The prediction end date can be changed by Credit_Suisse_Group_ at any time. Credit_Suisse_Group_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Stoke Therapeutics Inc 52.664% 52.664%
iShares Core DAX® 2.635% 3.881%
iShares Nasdaq 100 2.074% 2.844%
iShares Nikkei 225® 0.846% 6.239%
iShares S&P 500 1.587% 3.955%

Comments by Credit_Suisse_Group_ for this prediction

In the thread Stoke Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 51.64%
Target price 21.004
Change
Ends at 08.08.24

Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $23.00 price target on the stock.
Ratings data for STOK provided by MarketBeat